CEPI commits up to $50 million to develop Bundibugyo Ebola vaccine with Moderna
01/06/2026 10:11
CEPI commits up to $50 million to develop Bundibugyo Ebola vaccine with Moderna June 1 (Reuters) - Moderna MRNA.O said on Monday it has expanded its tie up with the Coalition for Epidemic Preparedness Innovations to advance the development of a potential vaccine against Bundibugyo ebolavirus.
Under the agreement, CEPI has committed up to $50 million to support preclinical development and early clinical testing of Moderna's investigational BDBV vaccine candidate, Moderna said.
(Reporting by Mariam Sunny in Bengaluru; Editing by Mrigank Dhaniwala)